Talk to enough Wall Street executives and you come away with something very unsettling: No one knows what’s going to happen with markets and, by extension, the economy — and it’s scary.

Wall Street analysts expect Royalty Pharma (RPRX) to post quarterly earnings of $0.99 per share in its upcoming report, which indicates a year-over-year increase of 1%. Revenues are expected to be ...